Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Lovastatin: Immunomodulatory Value Evaluation (LIVE)

This study has been completed.
Sponsor:
Collaborators:
Instituto Colombiano para el Desarrollo de Ciencia y Tecnología COLCIENCIAS
Laboratorio Clínico Congregación Mariana
Laboratorios Laproff S.A.
Humax Pharmaceutical
Information provided by (Responsible Party):
Carlos Julio Montoya Guarin, Universidad de Antioquia
ClinicalTrials.gov Identifier:
NCT00721305
First received: July 22, 2008
Last updated: September 30, 2011
Last verified: September 2011